St. Johns Investment Management’s Amedisys AMED Stock Holding History

St. Johns Investment Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-14	Closed	-$1.38K	–	205
2025 Q2	$1.38K	Hold	14	–	–	﹤0.01%	180
2025 Q1	$1.3K	Hold	14	–	–	﹤0.01%	171
2024 Q4	$1.27K	Hold	14	–	–	﹤0.01%	187
2024 Q3	$1.35K	Hold	14	–	–	﹤0.01%	206
2024 Q2	$1.28K	Hold	14	–	–	﹤0.01%	175
2024 Q1	$1.29K	Hold	14	–	–	﹤0.01%	187
2023 Q4	$1.33K	Hold	14	–	–	﹤0.01%	166
2023 Q3	$1.31K	Hold	14	–	–	﹤0.01%	162
2023 Q2	$1.28K	Hold	14	–	–	﹤0.01%	172
2023 Q1	$1.03K	Hold	14	–	–	﹤0.01%	160
2022 Q4	$1.17K	Hold	14	–	–	﹤0.01%	151
2022 Q3	$1K	Hold	14	–	–	﹤0.01%	156
2022 Q2	$1K	Hold	14	–	–	﹤0.01%	157
2022 Q1	$2K	Hold	14	–	–	﹤0.01%	159
2021 Q4	$2K	Buy	+14	New	+$2.25K	﹤0.01%	172

Other funds holding AMED

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

MCI

MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

St. Johns Investment Management's AMED Position: Q3 2025 in Review

St. Johns Investment Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 14 shares — an estimated $1.38K sold.

St. Johns Investment Management first reported a position in AMED in Q4 2021 and held it in 15 quarters. The position peaked at $2K in Q1 2022. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

St. Johns Investment Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
St. Johns Investment Management sold 14 Amedisys shares in Q3 2025, an estimated $1.38K.
St. Johns Investment Management first reported a position in Amedisys in Q4 2021 and held it in 15 quarters.
St. Johns Investment Management's Amedisys position peaked at $2K in Q1 2022.
4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on St. Johns Investment Management's 13F filing for Q3 2025, filed 27 Oct 2025.